EP0832197A4 - Virus de variole aviaire recombines et leurs utilisations - Google Patents

Virus de variole aviaire recombines et leurs utilisations

Info

Publication number
EP0832197A4
EP0832197A4 EP96924336A EP96924336A EP0832197A4 EP 0832197 A4 EP0832197 A4 EP 0832197A4 EP 96924336 A EP96924336 A EP 96924336A EP 96924336 A EP96924336 A EP 96924336A EP 0832197 A4 EP0832197 A4 EP 0832197A4
Authority
EP
European Patent Office
Prior art keywords
recombinant fowlpox
fowlpox viruses
viruses
recombinant
fowlpox
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP96924336A
Other languages
German (de)
English (en)
Other versions
EP0832197A1 (fr
Inventor
Mark D Cochran
David E Junker
Philip A Singer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Syntro Corp
Original Assignee
Syntro Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Syntro Corp filed Critical Syntro Corp
Publication of EP0832197A1 publication Critical patent/EP0832197A1/fr
Publication of EP0832197A4 publication Critical patent/EP0832197A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16311—Mardivirus, e.g. Gallid herpesvirus 2, Marek-like viruses, turkey HV
    • C12N2710/16334—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16311—Mardivirus, e.g. Gallid herpesvirus 2, Marek-like viruses, turkey HV
    • C12N2710/16341—Use of virus, viral particle or viral elements as a vector
    • C12N2710/16343—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/24011—Poxviridae
    • C12N2710/24034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/24011—Poxviridae
    • C12N2710/24041—Use of virus, viral particle or viral elements as a vector
    • C12N2710/24043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18111—Avulavirus, e.g. Newcastle disease virus
    • C12N2760/18134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18111—Avulavirus, e.g. Newcastle disease virus
    • C12N2760/18141—Use of virus, viral particle or viral elements as a vector
    • C12N2760/18143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Plant Pathology (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
EP96924336A 1995-06-07 1996-06-04 Virus de variole aviaire recombines et leurs utilisations Withdrawn EP0832197A4 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US484790 1983-04-14
US48479095A 1995-06-07 1995-06-07
PCT/US1996/011187 WO1996040880A1 (fr) 1995-06-07 1996-06-04 Virus de variole aviaire recombines et leurs utilisations

Publications (2)

Publication Number Publication Date
EP0832197A1 EP0832197A1 (fr) 1998-04-01
EP0832197A4 true EP0832197A4 (fr) 2002-10-16

Family

ID=23925610

Family Applications (1)

Application Number Title Priority Date Filing Date
EP96924336A Withdrawn EP0832197A4 (fr) 1995-06-07 1996-06-04 Virus de variole aviaire recombines et leurs utilisations

Country Status (5)

Country Link
EP (1) EP0832197A4 (fr)
JP (1) JPH11507241A (fr)
AU (1) AU729518B2 (fr)
CA (1) CA2223591A1 (fr)
WO (1) WO1996040880A1 (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU6518298A (en) * 1997-03-28 1998-10-22 Nippon Zeon Co., Ltd. Novel dna vector and vaccines containing novel recombinant dna vectors as the active ingredient
EP0974660A1 (fr) * 1998-06-19 2000-01-26 Stichting Instituut voor Dierhouderij en Diergezondheid (ID-DLO) Clones infectieux du virus de la maladie de Newcastle, vaccins et analyses diagnostiqués
MXPA02011545A (es) * 2000-05-24 2003-06-06 Merial Sas Virus del sindrome respiratorio y reproductor porcino (peesv), vacuna recombinante para el virus de la viruela.
WO2002102404A1 (fr) * 2001-06-18 2002-12-27 Institut National De La Recherche Agronomique Utilisations de cytokines
CN1330376C (zh) * 2001-09-30 2007-08-08 扬州大学 重组鸡痘病毒联合疫苗
DE10221411B4 (de) * 2002-05-14 2004-07-08 GSF-Forschungszentrum für Umwelt und Gesundheit GmbH Rekombinantes Fowlpox-Virus
GB2402391A (en) * 2003-06-04 2004-12-08 Oxxon Pharmaccines Ltd Fowlpox recombinant genome
ES2424847T3 (es) * 2004-06-25 2013-10-09 Merial Ltd. Genes del virus de la fiebre aftosa que expresan avipox recombinantes
PT2694101T (pt) 2011-04-06 2016-12-19 Université Paris Descartes Composições farmacêutivas para prevenção e/ou tratamento de doença por vih em seres humanos
JP2014236748A (ja) * 2014-08-26 2014-12-18 一般財団法人阪大微生物病研究会 組換え多価ワクチン

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1988000971A1 (fr) * 1986-08-01 1988-02-11 Commonwealth Scientific And Industrial Research Or Vaccin recombinant
EP0520753A1 (fr) * 1991-06-28 1992-12-30 THE UNITED STATES OF AMERICA as represented by THE SECRETARY OF AGRICULTURE Vaccin recombinant issu du virus de la variole aviaire pour la protection contre la maladie de Marek
US5258294A (en) * 1988-02-12 1993-11-02 Commonwealth Scientific And Industrial Research Organisation Bidirectional pox virus promoter element
WO1994016716A1 (fr) * 1993-01-21 1994-08-04 Virogenetics Corporation Immunotherapie par virus recombine
WO1994019015A1 (fr) * 1993-02-26 1994-09-01 Syntro Corporation Virus recombinants de la diphterie des volailles et utilisations
US5403582A (en) * 1993-01-21 1995-04-04 Nippon Zeon Co., Ltd. Vaccine comprising fowlpox virus recombinants expressing the envelope glycoprotein of an avian reticuloendotheliosis retrovirus

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5505941A (en) * 1981-12-24 1996-04-09 Health Research, Inc. Recombinant avipox virus and method to induce an immune response
JP2531729B2 (ja) * 1987-03-27 1996-09-04 日本ゼオン株式会社 組み換えアビポックスウイルス
US5286639A (en) * 1987-09-16 1994-02-15 Nippon Zeon Co., Ltd. Recombinant avipoxvirus
FR2632863B2 (fr) * 1987-10-29 1990-08-31 Transgene Sa Virus du fowlpox recombinant et vaccins derives de ces virus
GB8917059D0 (en) * 1989-07-26 1989-09-13 Nat Res Dev Avipox virus promoters

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1988000971A1 (fr) * 1986-08-01 1988-02-11 Commonwealth Scientific And Industrial Research Or Vaccin recombinant
US5258294A (en) * 1988-02-12 1993-11-02 Commonwealth Scientific And Industrial Research Organisation Bidirectional pox virus promoter element
EP0520753A1 (fr) * 1991-06-28 1992-12-30 THE UNITED STATES OF AMERICA as represented by THE SECRETARY OF AGRICULTURE Vaccin recombinant issu du virus de la variole aviaire pour la protection contre la maladie de Marek
WO1994016716A1 (fr) * 1993-01-21 1994-08-04 Virogenetics Corporation Immunotherapie par virus recombine
US5403582A (en) * 1993-01-21 1995-04-04 Nippon Zeon Co., Ltd. Vaccine comprising fowlpox virus recombinants expressing the envelope glycoprotein of an avian reticuloendotheliosis retrovirus
WO1994019015A1 (fr) * 1993-02-26 1994-09-01 Syntro Corporation Virus recombinants de la diphterie des volailles et utilisations

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
BOURSNELL ET AL: "Avipoxvirus vectors", RECOMBINANT POXVIRUSES, XX, XX, June 1992 (1992-06-01), pages 269 - 283, XP002090113 *
BOYLE D B ET AL: "RECOMBINANT FOWLPOX VIRUS VACCINES FOR POULTRY", IMMUNOLOGY AND CELL BIOLOGY, CARLTON, AU, vol. 71, no. PART 5, 1 October 1993 (1993-10-01), pages 391 - 397, XP000609353 *
LEONG KAH HOO ET AL: "Selective induction of immune responses by cytokines coexpressed in recombinant fowlpox virus.", JOURNAL OF VIROLOGY, vol. 68, no. 12, 1994, pages 8125 - 8130, XP001094774, ISSN: 0022-538X *
See also references of WO9640880A1 *

Also Published As

Publication number Publication date
AU729518B2 (en) 2001-02-01
WO1996040880A1 (fr) 1996-12-19
EP0832197A1 (fr) 1998-04-01
CA2223591A1 (fr) 1996-12-19
AU6481996A (en) 1996-12-30
JPH11507241A (ja) 1999-06-29

Similar Documents

Publication Publication Date Title
HUP9802217A3 (en) Recombinant mva virus, and the use thereof
IL122428A0 (en) Minizymes and minribozymes and uses thereof
IL128529A0 (en) Anti-inflammatory peptides and uses thereof
EP1021185A4 (fr) Dihydropyrimidines et leurs emplois
IL112860A0 (en) Recombinant viruses their preparation and their therapeutic uses
EP0894807A4 (fr) COMPLEXE GPIb-LIPIDE ET SES UTILISATIONS
EP0973924A4 (fr) Virus chimeres de recombinaison et leurs utilisations
ZA9610721B (en) Grapevine leafroll virus proteins and their uses.
HUP9902710A3 (en) Recombinant swinepox virus
HK1010153A1 (en) Recombinant human alpha-fetoprotein and uses thereof.
GB9705903D0 (en) VP22 Proteins and uses thereof
EP0696204A4 (fr) Virus recombinants de la diphterie des volailles et utilisations
PL318017A1 (en) Peptides
GB9500601D0 (en) Modified peptides
EP0832197A4 (fr) Virus de variole aviaire recombines et leurs utilisations
HUP0003327A3 (en) Grapevine leafroll virus (type 2) proteins and their uses
EP0710120A4 (fr) Suipoxvirus recombine
EP0914150A4 (fr) Nouveaux antigenes de recombinaison pour la lutte contre neospora et leurs utilisations
GB9423372D0 (en) Proteins and their uses
HUP9801330A3 (en) Novel pka-binding proteins and uses thereof
GB9425380D0 (en) Peptides
IL113725A0 (en) Preparing recombinant aprotini and its variants
KR960010685A (ko) 펩티드 및 그 용도
GB2336844B (en) Anti-hiv peptides and proteins
EP0692537A3 (fr) ADN récombinante codant pour gibberellin et son utilisation

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19980107

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

A4 Supplementary search report drawn up and despatched

Effective date: 20020830

AK Designated contracting states

Kind code of ref document: A4

Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

17Q First examination report despatched

Effective date: 20030807

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20040218